Similar sites
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/ARelman Colfax PLLC | Home
#progressive think tanks
#independent executive agencies
#assessing civil penalties for fair housing act cases
#national fair housing advocate
#keating memorandum
#fair housing disability
#fair housing
#housing discrimination cases
#keating memo
#housing discrimination award
#testing for fair housing compliance must
#which of the following actions is allowed under federal fair housing laws?
#national fair housing alliance
#lisa rice
#nfha 2018 dc conference
#relman dane &
# colfax
# colfax pllc
Category
N/AGlobal Rank
N/ARank in 1 month
14Estimate Value
N/A
#bruce wayne
#moon knight
#minecraft
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/A
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/ASalesforce Essentials is made for small businesses by the #1 CRM, helping you organize and track customers, sales, and support — all in one app.
Malware Scan Info
Macafee Check : 
Email address with relmada.com
Recent Searched Sites
Sofitel-hamburg-alter-wall-hotel.ibooked.at (35 seconds ago) / US
Vincentdampt.com (42 seconds ago) / FR
Relmada.com (0 seconds ago) / US
Godiva.com (18 seconds ago) / US
Hedefgirisim.com.tr (1 mins ago) / US
Delbene.org (19 seconds ago) / US
Meoc.gov.bd (1 mins ago) / US
Mn.bridgetobenefits.org (17 seconds ago) / US
Fastsigns.com (1 mins ago) / US
Hairs.london (5 seconds ago) / US
Saynihao.online (13 seconds ago) / AU
Ravacanafilms.com (22 seconds ago) / ID
Sudofry.com (20 seconds ago) / US
Turkestan.atameken.kz (1 mins ago) / RU
Urbanmedspacharlotte.com (2 seconds ago) / US
Alfalaval.it (50 seconds ago) / SE
Upriteco.com (33 seconds ago) /
Basebridge.io (47 seconds ago) / US
Atmtxphoto.com (1 seconds ago) / US
Easygals.com (41 seconds ago) / NL
Domain Informations
Relmada.com lookup results from whois.networksolutions.com server:
- Domain created: 2011-04-26T00:19:04Z
- Domain updated: 2019-08-05T14:58:20Z
- Domain expires: 2028-04-26T00:19:04Z 3 Years, 300 Days left
- Website age: 13 Years, 65 Days
- Registrar Domain ID: 1652846001_DOMAIN_COM-VRSN
- Registrar Url: http://networksolutions.com
- Registrar WHOIS Server: whois.networksolutions.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +1.8777228662
- Name server:
- NS10.HUMBLEMONKEY.COM
- NS11.HUMBLEMONKEY.COM
- NS12.HUMBLEMONKEY.COM
- NS13.HUMBLEMONKEY.COM
Network
- inetnum : 54.208.0.0 - 54.209.255.255
- name : AMAZO-ZIAD4
- handle : NET-54-208-0-0-2
- status : Reallocated
- created : 2005-09-29
- changed : 2022-09-30
- desc : For details of this service please see,http://ec2.amazonaws.com
Owner
- organization : Amazon.com, Inc.
- handle : AMAZO-4
- address : Array,Seattle,WA,98108-1226,US
Technical support
- handle : ANO24-ARIN
- name : Amazon EC2 Network Operations
- phone : +1-206-555-0000
- email : [email protected]
Abuse
- handle : AEA8-ARIN
- name : Amazon EC2 Abuse
- phone : +1-206-555-0000
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 680399 |
| namecheap.com | 224489 |
| networksolutions.com | 166122 |
| tucows.com | 137881 |
| publicdomainregistry.com | 88119 |
| whois.godaddy.com | 62267 |
| enomdomains.com | 58221 |
| cloudflare.com | 49364 |
| namesilo.com | 48894 |
| gmo.jp | 46192 |
| register.com | 39024 |
| fastdomain.com | 38301 |
| ionos.com | 33869 |
| name.com | 32288 |
| wildwestdomains.com | 32212 |
| net.cn | 31018 |
| registrar.amazon.com | 30344 |
| dynadot.com | 27920 |
| key-systems.net | 27185 |
Host Informations
| Host name | ec2-54-208-101-55.compute-1.amazonaws.com |
| IP address | 54.208.101.55 |
| Location | Ashburn United States |
| Latitude | 39.0481 |
| Longitude | -77.4728 |
| Metro Code | 511 |
| Timezone | America/New_York |
| Postal | 20149 |
Port Scanner (IP: 54.208.101.55)
Spam Check (IP: 54.208.101.55) › Dnsbl-1.uceprotect.net:
› Dnsbl-2.uceprotect.net:
› Dnsbl-3.uceprotect.net:
› Dnsbl.dronebl.org:
› Dnsbl.sorbs.net:
› Spam.dnsbl.sorbs.net:
› Bl.spamcop.net:
› Recent.dnsbl.sorbs.net:
› All.spamrats.com:
› B.barracudacentral.org:
› Bl.blocklist.de:
› Bl.emailbasura.org:
› Bl.mailspike.org:
› Bl.spamcop.net:
› Cblplus.anti-spam.org.cn:
› Dnsbl.anticaptcha.net:
› Ip.v4bl.org:
› Fnrbl.fast.net:
› Dnsrbl.swinog.ch:
› Mail-abuse.blacklist.jippg.org:
› Singlebl.spamgrouper.com:
› Spam.abuse.ch:
› Spamsources.fabel.dk:
› Virbl.dnsbl.bit.nl:
› Cbl.abuseat.org:
› Dnsbl.justspam.org:
› Zen.spamhaus.org:
Keyword Suggestion
Site Inspections
Websites Listing
We found Websites Listing below when search with relmada.com on Search Engine
Relmada Therapeutics, Inc. (RLMD) Stock Price, News, …
Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today provided a …
Finance.yahoo.comDA: 17 PA: 11 MOZ Rank: 28
RLMD: Relmada Therapeutics Inc - Stock Price, Quote and …
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), which is …
Cnbc.comDA: 12 PA: 12 MOZ Rank: 25
RLMD Stock Price | Relmada Therapeutics Inc. Stock …
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor ...
Marketwatch.comDA: 19 PA: 21 MOZ Rank: 42
How to buy Relmada Therapeutics stock | 23 June price …
This would suggest that Relmada Therapeutics's shares are less volatile than average (for this exchange). Relmada Therapeutics overview. Relmada Therapeutics, Inc. , a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product ...
Finder.comDA: 14 PA: 34 MOZ Rank: 51
RLMD Stock Forecast, Price & News (Relmada Therapeutics)
The official website for Relmada Therapeutics is www.relmada.com. The company can be reached via phone at (646) 876-3459 or via email at [email protected]. This page (NASDAQ:RLMD) was last updated on 7/5/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00
Marketbeat.comDA: 18 PA: 20 MOZ Rank: 42
Relmada Therapeutics Announces Closing of Public Offering and …
Relmada's experienced and dedicated team is committed to making a difference in the lives of patients and their families. Relmada's lead program, REL-1017, is a new chemical entity (NCE) and novel ...
Prnewswire.comDA: 18 PA: 50 MOZ Rank: 45
RLMD Relmada Therapeutics Inc — Stock Price and Discussion
Relmada Therapeutics Inc NASDAQ Updated Jul 7, 2022 5:52 PM. RLMD 19.35 0.24 (1.26%). 814
Stocktwits.comDA: 14 PA: 12 MOZ Rank: 32
4 Clinical Catalysts On Tap For Relmada In 2022 - SeekingAlpha
PeopleImages/iStock via Getty Images. Relmada Therapeutics (NASDAQ:RLMD) is nearing the development finish line for its antidepressant REL-1017, with the year 2022 being make or break.This article ...
Seekingalpha.comDA: 16 PA: 50 MOZ Rank: 87
Insider Selling: Relmada Therapeutics, Inc. (NASDAQ:RLMD) CEO …
Relmada Therapeutics, Inc. (NASDAQ:RLMD – Get Rating) CEO Sergio Traversa sold 16,012 shares of the stock in a transaction on Thursday, June 30th. The shares were sold at an average price of $19 ...
Defenseworld.netDA: 20 PA: 50 MOZ Rank: 42
Relmada Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected]. Phone Number 646-876-3459. Relmada Therapeutics is a late-stage biotechnology company addressing diseases of the central nervous system (CNS), with a focus on major depressive disorder (MDD). Our experienced and dedicated team is committed to making a difference in the lives of patients and their families.
Crunchbase.comDA: 18 PA: 34 MOZ Rank: 61
Relmada Therapeutics, Inc. (RLMD) Stock Price, Quote & News
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in …
Stockanalysis.comDA: 17 PA: 13 MOZ Rank: 40
Relmada Therapeutics Inc Stock Scoreboard - Investing.com Canada
This page features our user's sentiments regarding the Relmada Therapeutics Inc share.
Ca.investing.comDA: 16 PA: 41 MOZ Rank: 68
Relmada Therapeutics Inc Stock Candlestick Chart (RLMD)
Dozens of bullish and bearish live candlestick chart patterns for the Relmada Therapeutics Inc stock.
Ca.investing.comDA: 16 PA: 42 MOZ Rank: 70
Relmada Therapeutics Announces Proposed Public Offering of
Relmada’s experienced and dedicated team is committed to making a difference in the lives of patients and their families. Relmada’s lead program, REL-1017, is a new chemical entity (NCE) and ...
Globenewswire.comDA: 21 PA: 50 MOZ Rank: 37
Transcript : Relmada Therapeutics, Inc., Q1 2022 Earnings Call, May …
Oppenheimer Adjusts Relmada Therapeutics' Price Target to $64 From $75, Maintains Outpe.. Goldman Sachs Adjusts Relmada Therapeutics' Price Target to $53 from $69, Keeps Buy Rat.. SVB Leerink Adjusts Relmada Therapeutics' Price Target to $42 from $50, Keeps Outperfor.. Chart RELMADA THERAPEUTICS, INC.
Marketscreener.comDA: 22 PA: 50 MOZ Rank: 36
Relmada Therapeutics Inc (RLMD) Stock Price & News - Google …
Get the latest Relmada Therapeutics Inc (RLMD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Google.comDA: 14 PA: 26 MOZ Rank: 55
Here's Why Relmada Therapeutics Stock Popped Today
Shares of Relmada Therapeutics ( RLMD -2.02%), a clinical-stage biopharmaceutical company, popped in response to a positive clinical trial readout with the company's lead candidate. Investors ...
Fool.comDA: 12 PA: 50 MOZ Rank: 100
We're Not Worried About Relmada Therapeutics's …
Relmada Therapeutics didn't record any revenue over the last year, indicating that it's an early stage company still developing its business. So while we can't look to sales to understand growth, we can look at how the cash burn is changing to understand how expenditure is trending over time. Over the last year its cash burn actually increased by a very significant …
Ca.news.yahoo.comDA: 17 PA: 50 MOZ Rank: 88
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| getfloormat.com | webnic.cc | 77 Days |
| montegray.com | tucows.com | 219 Days |